Back to search
JAZZ

Jazz Pharmaceuticals, Inc.

PHARMACEUTICAL PREPARATIONS +37.4% (1Y)
Confidence Score
71%
Current Price
$170.00
Open
$170.82
Day Range
$169.46 - $170.82
Volume
323,170
Market Cap
$10.33B
Employees
2,800
Website
www.jazzpharmaceuticals.com

Company Description

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex ...

Analysis Summary

Sleep and oncology franchises stable. Pipeline in movement disorders and cell therapy. Activist involvement may unlock value.

Pro Analysis Locked

Upgrade to Pro to unlock detailed financial analysis, historical data, comparable companies, and AI-generated research reports.

Upgrade to Pro View Pricing